AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02314169 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT03994614 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TEAS
Description: Patients in the experimental group will be given TEAS treatment for 12 weeks prior to COS. The patients will be given three times acupuncture every week except menstruation. The acupuncture acupoint locations are as follows: head acupoint Baihui(DU20), abdominal acupoint Zhongji (RN3), Guanyuan (RN4), Zigong(EX-CA1), leg acupoint Sanyinjiao(SP6), waist acupoint Shenyu (BL23) and Guanyuanyu(BL26).
Study NCT03145662 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: high pressure balloon
Description: high pressure balloon will be used to treat stenosis
Study NCT03145662 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: cutting balloon
Description: cutting balloon will be used to treat stenosis
Study NCT01696149 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcutaneous electrical nerve stimulation
Description: All subjects participated, randomly, in a 4 Hz TENS session, a 110 Hz TENS session, and a control (off-TENS) session. Each session consisted of a 20- minute stimulation period and a 10-minute follow up period.
Study NCT00732680 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum Toxin Type A
Description: 10 Units of Botulinum Toxin Type A injected into the dilator nasalis muscle on each side of the nose.
Study NCT03532815 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lifestyle Modification
Study NCT02432391 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GEM
Description: GEM is an integrated lifestyle modification program that focuses on reducing postprandial blood glucose through replacing high with low glycemic load foods and increasing routine physical activity guided by systematic blood glucose monitoring.
Study NCT01472965 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ethanol
Description: 70% ethanol catheter lock therapy
Study NCT01472965 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: heparin-saline placebo
Description: heparin-saline placebo catheter lock therapy
Study NCT01022775 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dynamic humeral centering
Description: Dynamic humeral centering performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.
Study NCT01022775 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nonspecific mobilisation
Description: Nonspecific mobilisation performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.
Study NCT01028248 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ranibizumab (Lucentis)
Description: 0.5mg and 2.0mg dose of Ranibizumab 0.05ml administered intravitreally
Study NCT04441476 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: An online questionnaire (Limesurvey platform) will be made available at 4 different times (M0, M1, M2 and M6).~* The first questionnaires (M0 and M1) will include a component for professional characterization. Generic and specific stress factors related to ICU and the current pandemic and collective and individual defensive strategies will also be collected in M0 and M1.~* At M2 and M6, the traumatic impact of the crisis, burnout, signs of depression and recourse to internal or external support in the department (occupational medicine, support unit) will be collected.
Study NCT04441476 — intervention group
Intervention type: OTHER
Intervention: psychological and sociological interviews
Description: conducting semi-directive psychological interviews (40 interviews in M2, 40 interviews in M6).~sociological interviews: 40 (20 in M1-M2 then 20 in M6) in order to understand the consequences of the epidemic on daily life, both intra-family and micro-social.
Study NCT00005604 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: recombinant interleukin-12
Description: Given IV
Study NCT00005604 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: aldesleukin
Description: Given SC
Study NCT00005604 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT01241617 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Duet TRS
Description: Endo GIA stapler with integrated Duet TRS
Study NCT01241617 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Endo GIA
Description: Endo GIA stapler with Single Use Loading Units
Study NCT02278367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flortaucipir F18
Description: IV injection, 370 MBq (10 mCi), up to two doses
Study NCT02278367 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Brain PET scan
Description: positron emission tomography (PET) scan of the brain
Study NCT04808232 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: progressive muscle relaxation exercise
Description: We used the muscle relaxation audio CD produced by the Turkish Psychologists Association. The CD consists of three parts; the 10-min first part includes definition and purpose of relaxation, and points to take into consideration during relaxation, the 30-min second part includes instructions with river sounds, and the 30-min third part includes only relaxing music without instructions. We used the second part of the audio record in this study. Following the instructions on the CD, the students tensed each muscle group from hands to feet, and then, all muscles in their face and body for approximately 10 s. The women breathed in, tensed a specific muscle group, and then relaxed it while breathing out. The relaxation step took 10-20 s before tensing the next muscle group. Thus, the women relaxed by tensing and relaxing the muscle groups in hands, arms, neck, shoulder, chest, stomach, hips, foot and fingers, and all muscles in the face and body.
Study NCT03968224 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin/Metformin
Description: Two tablets of Metformin 850 mg every 12 hours will be provided in combination with Dapagliflozin 10 mg per day. Each participant will receive diet and exercise intervention according to their BMI and current physical condition.
Study NCT03968224 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: Two tablets of Metformin 850 mg every 12 hours will be provided. Each participant will receive diet and exercise intervention according to their BMI and current physical condition.
Study NCT03430661 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-246475
Description: Lyophilized ACT-246475A to be reconstituted with 1 mL of water for injection
Study NCT03430661 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Description: Tablet for oral administration (300 or 600 mg)
Study NCT03430661 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasugrel
Description: Tablet for oral administration (60 mg)
Study NCT03430661 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching ACT-246475 placebo will consist of sterile 0.9% w/v sodium chloride solution
Study NCT02314169 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Given IV
Study NCT02212301 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: senofilcon A
Description: Each study contact lens will be worn as daily wear modality for a period of 2 weeks each.
Study NCT02212301 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: lotrafilcon B
Description: Each study contact lens will be worn as daily wear modality for a period of 2 weeks each.
Study NCT01641627 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: proprioceptive stimulation
Description: tendon vibrations and plantar stimulation with a therapeuthic orthosis, 4x30 min/day during 14 days
Study NCT03122405 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RAM sensors
Description: Noninvasive acoustic monitoring device
Study NCT04937205 — intervention group
Intervention type: BEHAVIORAL
Intervention: MOVE
Description: The MOVE physical activity support program is based on the Self-Determination Theory and targets autonomous motivation for physical activity by encouraging 1) choice in physical activity type (e.g. walking, household chores, yoga), 2) a meaningful, value-based rationale for engaging in physical activity, and 3) physical activity that is intrinsically enjoyable. MOVE was delivered during two, 60-75 minute group-based classes and one, 45 minute individualized 1:1 support session to enhance adherence to physical activity recommendations within a lifestyle weight loss program. The group-based classes included a combination of PowerPoint slides, participant handouts, and group-based discussions. All MOVE content was delivered by trained study staff.
Study NCT04730076 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Balloon Dilation
Description: The standard approach involves a gradual balloon dilation where the balloon is inflated then held at each balloon size for 30-60 seconds then inflated to the next largest balloon diameter size and repeated to the maximum diameter size of that catheter. The dilation session will be repeated as frequently and as many times as needed to achieve the balloon diameter size of 18mm at the discretion of the endoscopist.
Study NCT04730076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Progressive Balloon Dilation
Description: In the progressive approach, the balloon is continuously inflated over the course of 3-5 minutes starting at the smallest to the largest balloon diameter depending of the balloon catheter used. The dilation will be repeated every 2-3 weeks (total of 2-3 sessions). At the next endoscopic procedure, the balloon diameter used will be the next size up based on previous session.
Study NCT04101019 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: Intervention will include the SPGB block which will be performed by placing the patient supine with the neck extended and 1.5 ml of 5% lidocaine will be dripped into one or two nostrils.
Study NCT04101019 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline Solution
Description: Intervention will include the SPGB block which will be performed by placing the patient supine with the neck extended and 1.5 ml of saline will be dripped into one or two nostrils.
Study NCT02806596 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sevoflurane
Description: After at least 4 minutes of stable inspired sevoflurane concentration, that concentration will be titrated to obtain a targeted bispectral index (BIS) level required for perform laryngoscopy. This level was initially set at 40, based on a preliminary study showing that such level of BIS was obtained at the laryngoscopy after common general anesthesia induction. For the next patients, BIS target was set according to a sequential allocation method (up and down).
Study NCT03096977 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Scale for the assessment and rating of ataxia (SARA)
Description: Clinical evaluation of the manual dexterity through the SARA scale.
Study NCT03096977 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JAMAR hand dynamometer
Description: Clinical evaluation of the prehension force using a JAMAR Dynamometer.~The prehension effort is made with the arm along the body, forearm horizontal, elbow flexed at 90 degrees, wrist in neutral position. The handle of the dynamometer is set to the second notch. The effort required is maximum effort.~Verbal encouragement is given during four successive tentative: the last three are averaged.~Each effort will be separated by a rest period of one minute. Interval: 1 min - Repeat: 3 times per hand
Study NCT03096977 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vibratory sensibility testing
Description: Test carried out using a tuned fork applied to the styloid radial process.~Position of the evaluated: elbow to the body with forearms horizontal and the wrist in neutral position. Stimulate the tuning fork and apply it to the styloid process of the radius. Ask the patient to say when he no longer feels the vibration.~Repeat 3 times for each hand.
Study NCT03096977 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sermes and Weinstein test
Description: Instrumental, quantitative method of tactile pressure sensation (dermal contact at constant pressure) using monofilaments. The monofilaments bend when a threshold force is applied to them.There is a kit of 5 monofilaments, each one corresponding to a different functional level.~Familiarize the patient with the test, eyes open, on a normal healthy side. Determine the level of perception of the healthy side, eyes closed. Start with the finest monofilament. If the answer is negative, go to the next monofilament.~The monofilaments applications are randomly made in the Wynn Parry areas, 3 times / area for blue and green filaments, then 1 time / zone for others.~The monofilament must be applied in 1.5 sec, held 1.5 sec, removed in 1.5 sec. The patient must give a verbal response yes when he perceives the contact and the response time must be less than 3 sec.
Study NCT03096977 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Weber test
Description: Evaluate the discrimination of 2 motionless points. The tactile discrimination threshold is the smallest distance separating 2 simultaneous stimulations that are located and perceived separately.~The pressure stops at the whitening of the skin. The patient should specify if he feels one or two spikes.~To determine the discrimination threshold:~Perform 10 stimulations of the same spacing in the same area. The smallest interval for which 7 correct answers are obtained is retained as threshold value.~Perform the test 3 times.
Study NCT04098497 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile intervention
Description: The mobile intervention in this study consists of two components: 1) self-monitoring and 2) an ACT-based microintervention.~Self-monitoring: twice daily, participants will complete self-reports of mania, depression, medication adherence, and activity through the mobile app Lorevimo.~Microintervention: The microintervention will consist of one of 84 prompts that aim to target one of 6 processes targeted in ACT (contacting the present moment, defusion, acceptance, self-as-context, values, and committed action). At each time-point, participants have a 50% chance of receiving a microintervention question along with the daily self-monitoring assessments.
Study NCT02162914 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Regorafenib/active
Description: Subjects randomized to be treated with Regorafenib/active will receive once a day 160 mg po (four tablets of 40 mg) for 3 weeks of every 4 weeks cycle (3 weeks on and 1 week off) Duration of one cycle is 28 days
Study NCT02162914 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Regorafenib/placebo
Description: Subjects randomized to be treated with Regorafenib/placebo will receive once a day 160 mg po (four tablets of 40 mg) for 3 weeks of every 4 weeks cycle (3 weeks on and 1 week off) Duration of one cycle is 28 days
Study NCT00162552 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: pentoxifylline
Description: Patients with severe cirrhosis treated with Pentoxifylline
Study NCT00162552 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO
Description: Patients with severe cirrhosis treated with a placebo
Study NCT03595137 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sono with Device
Description: In Group D, simple needle guide device was attached to the sono probe. Device was designed to assist the detection of the puncture site. After induction of anesthesia, sono-guided internal jugular vein cannulation was performed.
Study NCT03595137 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sono only
Description: In group S, sono-guided internal jugular vein cannulation was performed after induction of anesthesia
Study NCT02486159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Herbal plaster (Sanfujiu)
Description: The Acupoint herbal plaster consisted of mustard seed, fumarate, asarum, angelica, cinnamon, and ginger at a ratio of 3:3:2:2:0.5:4, respectively. The treatment was prepared by dissolving the ginger in water and adding the powder to form a plaster. Mixtures were formed into cakes of approximately 1.5 × 1.5 × 0.5 cm3 and were held in position using plastic sheets.
Study NCT02486159 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Eight (8) acupuncture treatment sessions over 4 weeks were performed for each volunteer. The standard protocol for acupuncture treatment covered the most commonly treated acupoints for allergic rhinitis: LI4, ST36, LI20 in both sides, and EX-HN3. After insertion of needles at each acupoint, manual stimulation of needles on LI20 and EX-HN3 was repeated 3 times at 5-minute intervals. Electrostimulation was applied to the needles inserted in ST36 and LI4 with a frequency of 3-5 Hz, and the intensity was adjusted according to each volunteer's tolerance. All needles were removed 20 minutes later in each treatment session.
Study NCT01280383 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: non-invasive neurally adjusted ventilatory assist
Description: non-invasive neurally adjusted ventilatory assist in critically ill patients
Study NCT03101033 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mechanical epidural neuroplasty
Description: Guided by X-ray transillumination,an epidural needle will be inserted through sacral hiatus. A catheter （BS epidural catheter, BioSpine Co., Ltd, Korea） will be inserted through the epidural needle to the epidural space where disc herniation locates, mechanical adhesiolysis will be implemented.
Study NCT03101033 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Transforaminal epidural compound betamethasone injection
Description: Guided by X-ray transillumination, A puncture needle will be inserted to the intervertebral foramen in the vicinity of affected nerve root, and steroid injectant consists of 1 ml of Compound Betamethasone Injection (Diprospan®, Schering-Plough Labo N.V., Belgium) and 4ml of 0.2% lidocaine will be injected.
Study NCT03101033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caudal epidural compound betamethasone injection
Description: steroid injectant consists of 1 ml of Compound Betamethasone Injection (Diprospan® Schering-Plough Labo N.V., Belgium) and 4ml of 0.2% lidocaine will be injected through the epidural catheter after mechanical epidural neuroplasty.
Study NCT03101033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epidural hyaluronidase injection
Description: Hyaluronidase of 1500 IU （Sine®, SPH NO.1 Biochemical and Pharmaceutical Co., LTD）will be injected through the epidural catheter after mechanical epidural neuroplasty and caudal epidural compound betamethasone injection.
Study NCT01530659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NT-501
Description: Study participants will undergo surgery to have an NT-501 Encapsulated Cell Therapy implant placed into the study eye.
Study NCT01530659 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Non-penetrating sham procedure to mimic implant procedure in the other eye.
Study NCT04957407 — intervention group
Intervention type: OTHER
Intervention: pepsinogen
Description: diagnostic value of pepsinogen for severe atrophy and gastric cancer
Study NCT00014222 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: epoetin alfa
Description: 40,000 IU
Study NCT00014222 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: filgrastim
Description: 5 mg/kg/d - days 2-13
Study NCT00014222 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cyclophosphamide
Description: 75, 600 and 830 mg/m2
Study NCT00014222 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: doxorubicin hydrochloride
Description: 60 mg/m2
Study NCT00014222 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: epirubicin hydrochloride
Description: 60 mg/m2
Study NCT00014222 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluorouracil
Description: 500mg/m2
Study NCT00014222 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paclitaxel
Description: 175 mg/m2
Study NCT02230423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nasal surgery
Study NCT00372177 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Fab-fragment of Anti-human CD4
Description: Sterile lyophilized Powder for Preparation of a Solution and sterile labelling Buffer labelling with Tc99m-Pertechnetat Intravenous injection
Study NCT01673295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RTX infusions
Description: RTX + Standard of Care
Study NCT01673295 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Standard of Care only
Study NCT00418418 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary bypass operation
Description: Coronary bypass operation is performed via sternotomy during cardiac arrest.
Study NCT00418418 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Coronary bypass operation
Description: Coronary bypass operation is performed via sternotomy during cardiac arrest.
Study NCT00418418 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bone marrow aspiration (crista iliaca)
Description: The bone marrow is aspirated from the iliac crest (100ml). During the operation the aspirate is transported to the stem cell laboratory, where the sample is centrifugated through Ficoll(Registered Trademark).